Bladder Neoplasm

Curated

← investigated for

Vinfluninesmall_molecule

unknown

Curated

← investigated for

Vinblastinesmall_molecule

unknown

Curated

← investigated for

Valrubicinsmall_molecule

unknown

Curated

← investigated for

Tremelimumabmonoclonal_antibody

unknown

Curated

← investigated for

Toripalimabmonoclonal_antibody

unknown

Curated

← investigated for

Tislelizumabmonoclonal_antibody

unknown

Curated

← investigated for

Tegafursmall_molecule

unknown

Curated

← investigated for

Sirolimussmall_molecule

unknown

Curated

← investigated for

Ramucirumabmonoclonal_antibody

unknown

Curated

← investigated for

Pemetrexedsmall_molecule

unknown

Curated

← investigated for

Pembrolizumabmonoclonal_antibody

unknown

Curated

← investigated for

Paclitaxelsmall_molecule

unknown

Curated

← investigated for

Nivolumabmonoclonal_antibody

unknown

Curated

← investigated for

Niacinamidesmall_molecule

unknown

Curated

← investigated for

Nadofaragene Firadenovecgene_therapy

unknown

Curated

← investigated for

Mitomycinsmall_molecule

unknown

Curated

← investigated for

Methotrexatesmall_molecule

unknown

Curated

← investigated for

Lenvatinibsmall_molecule

unknown

Curated

← investigated for

Infigratinibsmall_molecule

unknown

Curated

← investigated for

Gemcitabinesmall_molecule

unknown

Curated

← investigated for

Gefitinibsmall_molecule

unknown

Curated

← investigated for

Fluorouracilsmall_molecule

unknown

Curated

← investigated for

Filgrastimother

unknown

Curated

← investigated for

Epirubicinsmall_molecule

unknown

Curated

← investigated for

Enfortumab Vedotinadc

unknown

Curated

← investigated for

Durvalumabmonoclonal_antibody

unknown

Curated

← investigated for

Doxorubicinsmall_molecule

unknown

Curated

← investigated for

Docetaxelsmall_molecule

unknown

Curated

← investigated for

unknown

Curated

← investigated for

Cisplatinsmall_molecule

unknown

Curated

← investigated for

Carboplatinsmall_molecule

unknown

Curated

← investigated for

Atezolizumabmonoclonal_antibody

unknown

Curated

← investigated for

Vorinostatsmall_molecule

unknown

Curated

← investigated for

Vandetanibsmall_molecule

unknown

Curated

← investigated for

Trastuzumabmonoclonal_antibody

unknown

Curated

← investigated for

Tipifarnibsmall_molecule

unknown

Curated

← investigated for

Temsirolimussmall_molecule

unknown

Curated

← investigated for

Tamoxifensmall_molecule

unknown

Curated

← investigated for

Talazoparibsmall_molecule

unknown

Curated

← investigated for

Sunitinibsmall_molecule

unknown

Curated

← investigated for

Sorafenib Tosylatesmall_molecule

unknown

Curated

← investigated for

Sorafenibsmall_molecule

unknown

Curated

← investigated for

Sapanisertibsmall_molecule

unknown

Curated

← investigated for

Sacituzumab Govitecanadc

unknown

Curated

← investigated for

Romidepsinother

unknown

Curated

← investigated for

Rogaratinibsmall_molecule

unknown

Curated

← investigated for

Retifanlimabmonoclonal_antibody

unknown

Curated

← investigated for

Pemigatinibsmall_molecule

unknown

Curated

← investigated for

Pegfilgrastimother

unknown

Curated

← investigated for

Pazopanibsmall_molecule

unknown

Curated

← investigated for

Panitumumabmonoclonal_antibody

unknown

Curated

← investigated for

Palbociclibsmall_molecule

unknown

Curated

← investigated for

Oxaliplatinsmall_molecule

unknown

Curated

← investigated for

Olaparibsmall_molecule

unknown

Curated

← investigated for

Niraparibsmall_molecule

unknown

Curated

← investigated for

Nintedanibsmall_molecule

unknown

Curated

← investigated for

Mocetinostatsmall_molecule

unknown

Curated

← investigated for

Metforminsmall_molecule

unknown

Curated

← investigated for

Lonafarnibsmall_molecule

unknown

Curated

← investigated for

Lenalidomidesmall_molecule

unknown

Curated

← investigated for

Lapatinibsmall_molecule

unknown

Curated

← investigated for

Irinotecansmall_molecule

unknown

Curated

← investigated for

Ipilimumabmonoclonal_antibody

unknown

Curated

← investigated for

Ifosfamidesmall_molecule

unknown

Curated

← investigated for

Guadecitabinesmall_molecule

unknown

Curated

← investigated for

Futibatinibsmall_molecule

unknown

Curated

← investigated for

Fexagratinibsmall_molecule

unknown

Curated

← investigated for

Everolimussmall_molecule

unknown

Curated

← investigated for

Erlotinib Hydrochloridesmall_molecule

unknown

Curated

← investigated for

Erlotinibsmall_molecule

unknown

Curated

← investigated for

Enzalutamidesmall_molecule

unknown

Curated

← investigated for

Dovitinibsmall_molecule

unknown

Curated

← investigated for

Dexamethasonesmall_molecule

unknown

Curated

← investigated for

Cetuximabmonoclonal_antibody

unknown

Curated

← investigated for

Celecoxibsmall_molecule

unknown

Curated

← investigated for

Camrelizumabmonoclonal_antibody

unknown

Curated

← investigated for

Cabozantinibsmall_molecule

unknown

Curated

← investigated for

Cabazitaxelsmall_molecule

unknown

Curated

← investigated for

Bortezomibsmall_molecule

unknown

Curated

← investigated for

Bicalutamidesmall_molecule

unknown

Curated

← investigated for

Bevacizumabmonoclonal_antibody

unknown

Curated

← investigated for

Avelumabmonoclonal_antibody

unknown

Curated

← investigated for

Arsenic Trioxidesmall_molecule

unknown

Curated

← investigated for

Amrubicinsmall_molecule

unknown

Curated

← investigated for

Alisertibsmall_molecule

unknown

Curated

← investigated for

Aldesleukinother

unknown

Curated

← investigated for

Afliberceptother

unknown

Curated

← investigated for

Vistusertibsmall_molecule

unknown

Curated

← investigated for

Vinorelbinesmall_molecule

unknown

Curated

← investigated for

Tovorafenibsmall_molecule

unknown

Curated

← investigated for

Tazemetostatsmall_molecule

unknown

Curated

← investigated for

Tanespimycinsmall_molecule

unknown

Curated

← investigated for

Selumetinibsmall_molecule

unknown

Curated

← investigated for

Selinexorsmall_molecule

unknown

Curated

← investigated for

Picoplatinsmall_molecule

unknown

Curated

← investigated for

Padeliporfinsmall_molecule

unknown

Curated

← investigated for

Obinutuzumabmonoclonal_antibody

unknown

Curated

← investigated for

Leucovorinsmall_molecule

unknown

Curated

← investigated for

Fulvestrantsmall_molecule

unknown

Curated

← investigated for

Eribulinsmall_molecule

unknown

Curated

← investigated for

Derazantinibsmall_molecule

unknown

Curated

← investigated for

Cyclophosphamidesmall_molecule

unknown

Curated

← investigated for

Copanlisibsmall_molecule

unknown

Curated

← investigated for

Cemiplimabmonoclonal_antibody

unknown

Curated

← investigated for

Catumaxomabmonoclonal_antibody

unknown

Curated

← investigated for

Capecitabinesmall_molecule

unknown

Curated

← investigated for

Bosutinibsmall_molecule

unknown

Curated

← investigated for

Belinostatsmall_molecule

unknown

Curated

← investigated for

Adavosertibsmall_molecule

unknown

Curated

← investigated for

Valproic Acidsmall_molecule

unknown

0.5

Curated

← investigated for

Abemaciclibsmall_molecule

unknown

0.5

Curated

Bladder Neoplasm altered in cohorts of …ALTERED_INderived15 of 408show all (up to 200)
← altered in cohorts of	CDH1 27 / 34 cases (79 %) · ssm · blca_plasmacytoid_mskcc_2016	—	—	Bladder Urothelial Carcinoma	1	Observed	cbioportal	graph →
← altered in cohorts of	CDKN2B 267 / 412 cases (65 %) · ssm · TCGA-BLCA	—	—	Bladder Urothelial Carcinoma	1	Observed	gdc	graph →
← altered in cohorts of	MTAP 261 / 412 cases (63 %) · ssm · TCGA-BLCA	—	—	Bladder Urothelial Carcinoma	1	Observed	gdc	graph →
← altered in cohorts of	UBR5 259 / 412 cases (63 %) · ssm · TCGA-BLCA · largest of 4 cohorts	—	—	Bladder Urothelial Carcinoma	4	Observed	gdc	graph →
← altered in cohorts of	DMRTA1 255 / 412 cases (62 %) · ssm · TCGA-BLCA	—	—	Bladder Urothelial Carcinoma	1	Observed	gdc	graph →
← altered in cohorts of	GRHL2 255 / 412 cases (62 %) · ssm · TCGA-BLCA	—	—	Bladder Urothelial Carcinoma	1	Observed	gdc	graph →
← altered in cohorts of	COL14A1 253 / 412 cases (61 %) · ssm · TCGA-BLCA · largest of 4 cohorts	—	—	Bladder Urothelial Carcinoma	4	Observed	gdc	graph →
← altered in cohorts of	MYOM2 253 / 412 cases (61 %) · ssm · TCGA-BLCA	—	—	Bladder Urothelial Carcinoma	1	Observed	gdc	graph →
← altered in cohorts of	PABPC1 253 / 412 cases (61 %) · ssm · TCGA-BLCA	—	—	Bladder Urothelial Carcinoma	1	Observed	gdc	graph →
← altered in cohorts of	TEX15 253 / 412 cases (61 %) · ssm · TCGA-BLCA	—	—	Bladder Urothelial Carcinoma	1	Observed	gdc	graph →
← altered in cohorts of	TNFRSF10A 253 / 412 cases (61 %) · ssm · TCGA-BLCA	—	—	Bladder Urothelial Carcinoma	1	Observed	gdc	graph →
← altered in cohorts of	ZNF706 253 / 412 cases (61 %) · ssm · TCGA-BLCA	—	—	Bladder Urothelial Carcinoma	1	Observed	gdc	graph →
← altered in cohorts of	ADRA1A 252 / 412 cases (61 %) · ssm · TCGA-BLCA	—	—	Bladder Urothelial Carcinoma	1	Observed	gdc	graph →
← altered in cohorts of	RIMS2 252 / 412 cases (61 %) · ssm · TCGA-BLCA	—	—	Bladder Urothelial Carcinoma	1	Observed	gdc	graph →
← altered in cohorts of	CDCA2 251 / 412 cases (61 %) · ssm · TCGA-BLCA	—	—	Bladder Urothelial Carcinoma	1	Observed	gdc	graph →

Bladder Neoplasm altered in cohorts of …ALTERED_INderived15 of 408show all (up to 200)

← altered in cohorts of

CDH1

27 / 34 cases (79 %) · ssm · blca_plasmacytoid_mskcc_2016

—

Observed

cbioportal

← altered in cohorts of

CDKN2B

267 / 412 cases (65 %) · ssm · TCGA-BLCA

—

Observed

← altered in cohorts of

MTAP

261 / 412 cases (63 %) · ssm · TCGA-BLCA

—

Observed

← altered in cohorts of

UBR5

259 / 412 cases (63 %) · ssm · TCGA-BLCA · largest of 4 cohorts

—

Observed

← altered in cohorts of

DMRTA1

255 / 412 cases (62 %) · ssm · TCGA-BLCA

—

Observed

← altered in cohorts of

GRHL2

255 / 412 cases (62 %) · ssm · TCGA-BLCA

—

Observed

← altered in cohorts of

COL14A1

253 / 412 cases (61 %) · ssm · TCGA-BLCA · largest of 4 cohorts

—

Observed

← altered in cohorts of

MYOM2

253 / 412 cases (61 %) · ssm · TCGA-BLCA

—

Observed

← altered in cohorts of

PABPC1

253 / 412 cases (61 %) · ssm · TCGA-BLCA

—

Observed

← altered in cohorts of

TEX15

253 / 412 cases (61 %) · ssm · TCGA-BLCA

—

Observed

← altered in cohorts of

TNFRSF10A

253 / 412 cases (61 %) · ssm · TCGA-BLCA

—

Observed

← altered in cohorts of

ZNF706

253 / 412 cases (61 %) · ssm · TCGA-BLCA

—

Observed

← altered in cohorts of

ADRA1A

252 / 412 cases (61 %) · ssm · TCGA-BLCA

—

Observed

← altered in cohorts of

RIMS2

252 / 412 cases (61 %) · ssm · TCGA-BLCA

—

Observed

← altered in cohorts of

CDCA2

251 / 412 cases (61 %) · ssm · TCGA-BLCA

—

Observed

Bladder Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 147show all (up to 200)
→ investigated in trials for	Gemcitabinesmall_molecule 142 trials (45 active) · roll-up of the cancer and its descendants	—	—	Bladder Neoplasm	142	Observed	clinicaltrials	graph →
→ investigated in trials for	Cisplatinsmall_molecule 109 trials (34 active) · roll-up of the cancer and its descendants	—	—	Bladder Neoplasm	109	Observed	clinicaltrials	graph →
→ investigated in trials for	Pembrolizumabmonoclonal_antibody 76 trials (43 active) · roll-up of the cancer and its descendants	—	—	Bladder Neoplasm	76	Observed	clinicaltrials	graph →
→ investigated in trials for	Mitomycinsmall_molecule 41 trials (18 active) · roll-up of the cancer and its descendants	—	—	Bladder Neoplasm	41	Observed	clinicaltrials	graph →
→ investigated in trials for	Paclitaxelsmall_molecule 41 trials (5 active) · roll-up of the cancer and its descendants	—	—	Bladder Neoplasm	41	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatinsmall_molecule 37 trials (10 active) · roll-up of the cancer and its descendants	—	—	Bladder Neoplasm	37	Observed	clinicaltrials	graph →
→ investigated in trials for	Nivolumabmonoclonal_antibody 36 trials (16 active) · roll-up of the cancer and its descendants	—	—	Bladder Neoplasm	36	Observed	clinicaltrials	graph →
→ investigated in trials for	Durvalumabmonoclonal_antibody 31 trials (16 active) · roll-up of the cancer and its descendants	—	—	Bladder Neoplasm	31	Observed	clinicaltrials	graph →
→ investigated in trials for	Enfortumab Vedotinadc 30 trials (24 active) · roll-up of the cancer and its descendants	—	—	Bladder Neoplasm	30	Observed	clinicaltrials	graph →
→ investigated in trials for	Docetaxelsmall_molecule 28 trials (10 active) · roll-up of the cancer and its descendants	—	—	Bladder Neoplasm	28	Observed	clinicaltrials	graph →
→ investigated in trials for	Atezolizumabmonoclonal_antibody 26 trials (12 active) · roll-up of the cancer and its descendants	—	—	Bladder Neoplasm	26	Observed	clinicaltrials	graph →
→ investigated in trials for	Doxorubicinsmall_molecule 23 trials (2 active) · roll-up of the cancer and its descendants	—	—	Bladder Neoplasm	23	Observed	clinicaltrials	graph →
→ investigated in trials for	Fluorouracilsmall_molecule 19 trials (11 active) · roll-up of the cancer and its descendants	—	—	Bladder Neoplasm	19	Observed	clinicaltrials	graph →
→ investigated in trials for	Methotrexatesmall_molecule 19 trials (3 active) · roll-up of the cancer and its descendants	—	—	Bladder Neoplasm	19	Observed	clinicaltrials	graph →
→ investigated in trials for	Vinblastinesmall_molecule 18 trials (3 active) · roll-up of the cancer and its descendants	—	—	Bladder Neoplasm	18	Observed	clinicaltrials	graph →

Bladder Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 147show all (up to 200)

→ investigated in trials for

Gemcitabinesmall_molecule

142 trials (45 active) · roll-up of the cancer and its descendants

—

142

Observed

→ investigated in trials for

Cisplatinsmall_molecule

109 trials (34 active) · roll-up of the cancer and its descendants

—

109

Observed

→ investigated in trials for

Pembrolizumabmonoclonal_antibody

76 trials (43 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mitomycinsmall_molecule

41 trials (18 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Paclitaxelsmall_molecule

41 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Carboplatinsmall_molecule

37 trials (10 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nivolumabmonoclonal_antibody

36 trials (16 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Durvalumabmonoclonal_antibody

31 trials (16 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Enfortumab Vedotinadc

30 trials (24 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Docetaxelsmall_molecule

28 trials (10 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Atezolizumabmonoclonal_antibody

26 trials (12 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Doxorubicinsmall_molecule

23 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fluorouracilsmall_molecule

19 trials (11 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Methotrexatesmall_molecule

19 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vinblastinesmall_molecule

18 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

Bladder Neoplasm studied in …STUDIED_INderived10 of 1,701show all (up to 200)
→ studied in	NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active)	—	—	Bladder Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped CURATED_BROADER · 1,701 trials mapped (526 active)	—	—	Bladder Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04502095Phase 4 · completed Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active)	—	—	Bladder Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05891171Phase 1 · active not recruiting Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active)	—	—	Malignant Bladder Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT05987241Phase 2/Phase 3 · recruiting Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active)	—	—	Muscle Invasive Bladder Urothelial Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07061964Phase 2 · recruiting Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active)	—	—	Muscle Invasive Bladder Urothelial Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04235764recruiting En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active)	—	—	Malignant Bladder Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT04235777Phase 1 · active not recruiting Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active)	—	—	Malignant Bladder Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT05007106Phase 2 · completed MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) · condition mapped ALIAS · 1,701 trials mapped (526 active)	—	—	Bladder Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT06331299Phase 3 · active not recruiting A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active)	—	—	Malignant Bladder Neoplasm	1	Observed	clinicaltrials	graph →

Bladder Neoplasm studied in …STUDIED_INderived10 of 1,701show all (up to 200)

→ studied in

NCT02465060Phase 2 · active not recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active)

—

Bladder Carcinoma

Observed

→ studied in

NCT03866382Phase 2 · recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped CURATED_BROADER · 1,701 trials mapped (526 active)

—

Bladder Adenocarcinoma

Observed

→ studied in

NCT04502095Phase 4 · completed

Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active)

—

Bladder Carcinoma

Observed

→ studied in

NCT05891171Phase 1 · active not recruiting

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active)

—

Observed

Muscle Invasive Bladder Urothelial Carcinoma

→ studied in

NCT05987241Phase 2/Phase 3 · recruiting

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active)

—

Observed

Muscle Invasive Bladder Urothelial Carcinoma

→ studied in

NCT07061964Phase 2 · recruiting

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial · condition mapped ONTOLOGY_EXACT · 1,701 trials mapped (526 active)

—

Observed

→ studied in

NCT04235764recruiting

En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active)

—

Observed

→ studied in

NCT04235777Phase 1 · active not recruiting

Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active)

—

Observed

→ studied in

NCT05007106Phase 2 · completed

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) · condition mapped ALIAS · 1,701 trials mapped (526 active)

—

Observed

→ studied in

NCT06331299Phase 3 · active not recruiting

A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer · condition mapped CURATED_EXACT · 1,701 trials mapped (526 active)

—

Observed